530 filings
Page 21 of 27
8-K
df8fn
20 Sep 04
Other Events
12:00am
8-K
llwr 8kc7
1 Sep 04
Other Events
12:00am
8-K
we8ch6 qt
5 Aug 04
Amylin Pharmaceuticals Reports Second Quarter Financial Results
12:00am
424B3
nwt9ynuki83xwn
26 Jul 04
Prospectus supplement
12:00am
424B3
q7jyjrz2aro
23 Jul 04
Prospectus supplement
12:00am
8-K
g6cpdl4i7krjo8bp2zg
23 Jul 04
Current report
12:00am
10-K/A
egw5mn8edxte4d8uytb
15 Jul 04
Annual report (amended)
12:00am
8-K
7dkv3tb
30 Jun 04
New Drug Application for Exenatide Submitted to FDA for Type 2 Diabetes
12:00am
8-K
ygoojb6pvo a2gqho
8 Jun 04
Data From Pivotal Studies to Form the Basis of a Mid-2004 FDA Submission
12:00am
8-K
0fcchq20 ta7mpku
21 May 04
Amylin Pharmaceuticals Announces Acceptance of 17 Abstracts for Publication at the American Diabetes Association Annual Meeting
12:00am
S-8
y5sw9xpy4zq3o ywfqgc
5 May 04
Registration of securities for employees
12:00am
8-K
twtzsh06xgebsk2izk3
28 Apr 04
Financial statements and exhibits
12:00am
REGDEX
f6nuvgz7ny
28 Apr 04
Notice of sale of securities
12:00am
8-K
mom7ugv ad1ev8v9lwa
6 Apr 04
Amylin Pharmaceuticals, Inc. Announces Exercise of Initial Purchasers’ Option for Additional $25 Million of Convertible Senior Notes
12:00am
8-K
l6tubakstvw1x 7wle
1 Apr 04
Amylin Pharmaceuticals, Inc. Announces Pricing Of Convertible Senior Notes
12:00am